These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22120252)

  • 21. Mass spectrometry-based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage.
    Mindt S; Tokhi U; Hedtke M; Groß HJ; Hänggi D
    J Clin Pharm Ther; 2020 Feb; 45(1):81-87. PubMed ID: 31421063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of Oral and Intra-arterial Nimodipine Administration After Aneurysmal Subarachnoid Haemorrhage - A Single-centre Study.
    Ehrlich G; Kirschning T; Wenz H; Hegewald AA; Neumaier-Probst E; Seiz-Rosenhagen M
    In Vivo; 2019; 33(6):1967-1975. PubMed ID: 31662526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage.
    Macdonald RL; Hänggi D; Ko NU; Darsaut TE; Carlson AP; Wong GK; Etminan N; Mayer SA; Aldrich EF; Diringer MN; Ng D; Strange P; Bleck T; Grubb R; Suarez JI
    Neurosurgery; 2020 Dec; 88(1):E13-E26. PubMed ID: 32985652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study.
    Mahmoud SH; Hefny FR; Panos NG; Delucilla L; Ngan Z; Perreault MM; Hamilton LA; Rowe AS; Buschur PL; Owusu-Guha J; Almohaish S; Sandler M; Armahizer MJ; Barra ME; Cook AM; Barthol CA; Hintze TD; Cantin A; Traeger J; Blunck JR; Shewmaker J; Burgess SV; Kaupp K; Brown CS; Clark SL; Wieruszewski ED; Tesoro EP; Ammar AA; Ammar MA; Binning MJ; Naydin S; Fox N; Peters DM; Mahmoud LN; Keegan SP; Brophy GM
    Pharmacotherapy; 2023 Apr; 43(4):279-290. PubMed ID: 36880540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.
    Porchet F; Chioléro R; de Tribolet N
    Acta Neurochir (Wien); 1995; 137(1-2):62-9. PubMed ID: 8748871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of different nimodipine administration route for treating subarachnoid hemorrhage: A network meta-analysis.
    Lei G; Rao Z; Hu Y
    Medicine (Baltimore); 2023 Sep; 102(39):e34789. PubMed ID: 37773855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does nimodipine influence sex difference in outcome after aneurysmal subarachnoid haemorrhage?
    Hauerberg J; Rosenørn J; Skriver EB
    Acta Neurochir (Wien); 1996; 138(10):1168-71. PubMed ID: 8955435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic cisternal lavage in patients with aneurysmal subarachnoid hemorrhage with urokinase and nimodipine for the prevention of secondary brain injury (SPLASH): study protocol for a randomized controlled trial.
    Roelz R; Schubach F; Coenen VA; Jenkner C; Scheiwe C; Grauvogel J; Niesen WD; Urbach H; Taschner C; Seufert J; Kätzler J; Beck J; Reinacher PC
    Trials; 2021 Apr; 22(1):285. PubMed ID: 33858493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: a comparison with aneurysmal subarachnoid hemorrhage].
    Fukuda T; Mikoshiba M; Fukushima C; Nishi T; Nakajima S; Hasue M; Ikeda K; Sengoku Y; Ito H
    No Shinkei Geka; 1996 Aug; 24(8):723-31. PubMed ID: 8741407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Does nimodipine improve the outcome of perioperative complications of aneurysm rupture? Results of systematic treatment].
    Ades PE; Fabre M; Aesch B; Rieant JF; Buchet S; Lamotte C; Jan M
    Agressologie; 1989 Jun; 30(7):431-6. PubMed ID: 2817239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
    Musahl C; Henkes H; Vajda Z; Coburger J; Hopf N
    Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of functional outcome and quality of life following subarachnoid hemorrhage in patients treated with and without nicardipine prolonged-release implants.
    Barth M; Thomé C; Schmiedek P; Weiss C; Kasuya H; Vajkoczy P
    J Neurosurg; 2009 May; 110(5):955-60. PubMed ID: 19216650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of nimodipine in enteral and parenteral administration in patients with aneurysmal subarachnoid hemorrhage.
    Abboud T; Andresen H; Koeppen J; Czorlich P; Duehrsen L; Stenzig J; Westphal M; Regelsberger J
    Acta Neurochir (Wien); 2015 May; 157(5):763-7. PubMed ID: 25701099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nimodipine in Clinical Practice: A Pharmacological Update.
    Clough B; Tenii J; Wee C; Gunter E; Griffin T; Aiyagari V
    J Neurosci Nurs; 2022 Feb; 54(1):19-22. PubMed ID: 34775392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.
    Pickard JD; Murray GD; Illingworth R; Shaw MD; Teasdale GM; Foy PM; Humphrey PR; Lang DA; Nelson R; Richards P
    BMJ; 1989 Mar; 298(6674):636-42. PubMed ID: 2496789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage and implications for regional neuromonitoring.
    Miller CM; Palestrant D
    Clin Neurol Neurosurg; 2012 Jul; 114(6):545-9. PubMed ID: 22176917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enteral or parenteral nimodipine treatment: a comparative pharmacokinetic study.
    Scheller C; Wienke A; Wurm F; Vogel AS; Simmermacher S; Prell J; Rachinger J; Koman G; Strauss C; Scheller K
    J Neurol Surg A Cent Eur Neurosurg; 2014 Mar; 75(2):84-90. PubMed ID: 23504671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.